pulmonary disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Age between 18 and 80 years old, regardless of gender; (2) Subjects are scheduled to undergo open or thoracoscopic lung surgery, with no limitation on surgical methods; (3) American Society of Anesthesiologists (ASA) score <3; (4) The subject or his/her guardian is able to understand the purpose of the study, have sufficient willingness to follow the study protocol, and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Subject is in active (subject is currently receiving systemic therapy) bacterial infection or fungal infection; (2) Systemic steroid medication (intravenous or oral) within 30 days prior to surgery; (3) Chemotherapy, radiotherapy or other neoadjuvant therapy within 30 days before surgery; (4) subject's one-second forced expiratory volume (FEV1)/expected value =50%, or one-second forced expiratory volume (FEV1)/forced vital capacity (FVC) =60%; (5) NYHA (New York Heart Association) cardiac function grade IV; (6) Surgery has been performed on the lungs; (7) Pregnant or lactating women; (8) Combined use of other stapler products other than test equipment;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prolonged air leakage;Satisfaction with the performance of surgical instruments post-operation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Surgical situation (intraoperative blood loss, intraoperative air leakage);Pre-discharge recovery status of the subject;Recovery status of the subject 30 days post-surgery; | — |
Countries
China
Contacts
Shanghai Chest Hospital